Learn about a patient support program offered by Novartis

Read about a program offered by Novartis for your patients beginning treatment

To help your patients get the facts they need as they begin treatment

DIRECT THEM TO THE TAFINLAR + MEKINIST PATIENT NAVIGATOR PROGRAM

YOUR TAFINLAR + MEKINIST SALES REP

Dear {{customText[Dr.|Mr.|Mrs.|Ms.]}} {{accLname}}:

{{customText[Thank you for taking the time to meet with me to discuss the Patient Navigator Program. You requested information about the program, and I am following up with relevant material.|I'm sorry we missed each other when I stopped by your office. However, below is information about the Patient Navigator Program for your review.|It's been a while since our last meeting, so I am sharing information about the Patient Navigator Program that may be of interest to you.|Per our recent conversation, I would like to share information about the Patient Navigator Program that may be useful for you, your staff, and your patients.|Below is additional information regarding our recent discussion about the Patient Navigator Program.|I am following up with you regarding information I left with you about the Patient Navigator Program.|It was good speaking with you recently. I am providing you with additional information about the Patient Navigator Program, as discussed.|It was a pleasure speaking with you. As requested, I’m following up with further information about the Patient Navigator Program.]}}

ENCOURAGE YOUR PATIENTS TO UTILIZE
THE PATIENT NAVIGATOR PROGRAM

Patients can enroll in the program by calling 1-800-282-7630 and pressing option #3.

Upon enrollment, a trained Novartis professional will contact your patient by phone up to 4 times over the first 30 days of treatment.

Support topics covered in the calls include:

		How to start treatment		Tips on drug dosing, administration, and storage

		Available financial support		Pertinent treatment information

The program is detailed in the TAFINLAR^®(dabrafenib) capsules + MEKINIST^®(trametinib) tablets Patient Navigator Program Brochure, now available for both you and your patients to review.

Discuss the Patient Navigator Program Brochure with your patients after prescribing TAFINLAR + MEKINIST

{{customText[Should you like to follow up, I would be happy to share more information with you about the Patient Navigator Program. Please call me at the number below.|Because we haven't met recently, I invite you to call me to arrange a time when we can discuss additional Patient Navigator Program information.|Thank you for reviewing this information about the Patient Navigator Program. I hope you found it useful. Please do not hesitate to call me if you have any questions about the information provided or would like additional materials.|Because you requested this information, I want to answer any questions you may have. Please don't hesitate to call me if there is anything else you need.|If you have any questions, please call me for additional information.|Should you require more information, it would be my pleasure to speak to you. Please let me know when it would be a good time to further discuss the program.]}}

If you have any questions concerning e-mail or marketing communications from Novartis Pharmaceuticals Corporation, please call 1-888-NOW-NOVA (1-888-669-6682), Monday to Friday, 8:30 AM to 5:00 PM ET.

If you prefer not to receive e-mail communications about TAFINLAR + MEKINIST in this channel, please click here.

For more information, please visit the Novartis Privacy Policy.